# Jacob P. Thyssen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jacob-p-thyssen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 35,572 |
| Field | Dermatology and Skin Diseases |
| h-index | 92 |
| i10-index | 528 |
| Last Known Institution | Bispebjerg Hospital |
| OpenAlex ID | https://openalex.org/A5015006218 |
| ORCID iD | 0000-0003-3770-1743 |
| Works | 972 |

## Researcher papers

Showing 12 of 21.

- [European Society of Contact Dermatitis guideline for diagnostic patch testing – recommendations on best practice](https://scholariq.org/papers/european-society-of-contact-dermatitis-guideline-for-diagnostic-patch-testing/)
- [The epidemiology of contact allergy in the general population – prevalence and main findings](https://scholariq.org/papers/the-epidemiology-of-contact-allergy-in-the-general-population-prevalence-and/)
- [Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis](https://scholariq.org/papers/multi-ancestry-genome-wide-association-study-of-21-000-cases-and-95-000-controls/)
- [Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies](https://scholariq.org/papers/prevalence-of-psoriatic-arthritis-in-patients-with-psoriasis-a-systematic-review/)
- [Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial](https://scholariq.org/papers/efficacy-and-safety-of-abrocitinib-in-adults-and-adolescents-with-moderate-to/)
- [ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children](https://scholariq.org/papers/etfad-eadv-eczema-task-force-2020-position-paper-on-diagnosis-and-treatment-of/)
- [The epidemiology of hand eczema in the general population – prevalence and main findings<sup>*</sup>](https://scholariq.org/papers/the-epidemiology-of-hand-eczema-in-the-general-population-prevalence-and-main/)
- [Incidence and prevalence of rosacea: a systematic review and meta-analysis](https://scholariq.org/papers/incidence-and-prevalence-of-rosacea-a-systematic-review-and-meta-analysis/)
- [Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis](https://scholariq.org/papers/efficacy-and-safety-of-abrocitinib-in-patients-with-moderate-to-severe-atopic/)
- [Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis](https://scholariq.org/papers/causes-of-epidermal-filaggrin-reduction-and-their-role-in-the-pathogenesis-of/)
- [Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase<scp>III</scp>trials](https://scholariq.org/papers/baricitinib-in-patients-with-moderate-to-severe-atopic-dermatitis-and-inadequate/)
- [A systematic review and meta-analysis of the regional and age-related differences in atopic dermatitis clinical characteristics](https://scholariq.org/papers/a-systematic-review-and-meta-analysis-of-the-regional-and-age-related/)

## Researcher topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Contact Dermatitis and Allergies](https://scholariq.org/topics/contact-dermatitis-and-allergies/)
- [Allergic Rhinitis and Sensitization](https://scholariq.org/topics/allergic-rhinitis-and-sensitization/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)

## Researcher university

- [Bispebjerg Hospital](https://scholariq.org/institutions/bispebjerg-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
